Recombinetics (United States)

Recombinetics (United States)

Recombinetics is a St. Paul, Minnesota-based bio-engineering company. The company was founded in 2008, and has since raised $31 million from private investors. Mark Platt is the CEO. In November 2024, Recombinetics filed for Chapter 11 bankruptcy protection. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Recombinetics (United States), United States, covering academic research published from 2005 to 2024. Read More.


Open Access Percentage

74%


Total
Publications

182


Total Open
Publications

135


Total
Citations

6.6K


Open Access
Percentage

74%


Total
Publications

182


Total Open
Publications

135


Total
Citations

6.6K

Wikipedia

Website

download

Breakdown

19% 42% 13% 26%

Publisher Open

19%

Both

42%

Other Platform Open

13%

Closed

26%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022242628Total Publications
20052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

51%OA Journal

OA Journal 51%

57

Hybrid 35%

39

No Guarantees 14%

15

Other Platform Open

Domain 88%

89

Institution 25%

25

Preprint 13%

13

Public 9%

9

Other Internet 7%

7

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
88
Europe PMC
Domain
46
bioRxiv
Preprint
13
University of Edinburgh - Edinburgh Research Explorer
Institution
10
Ecole Polytechnique Fédérale de Lausanne - Infoscience
Institution
8
Semantic Scholar
Public
7
DOI
Other Internet
4
Red Federada de Repositorios Institucionales de Publicaciones Científicas - LA Referencia
Institution
3
iastate.edu OAI-PMH Repository
Institution
3
Alma Mater Studiorum Università di Bologna - Archivio istituzionale della ricerca - Alma Mater Studiorum Università di Bologna
Institution
3
1 / 3

Data updated 7 April 2025

Share

Share

Share